CN115335389A - 亲环蛋白抑制剂及其用途 - Google Patents

亲环蛋白抑制剂及其用途 Download PDF

Info

Publication number
CN115335389A
CN115335389A CN202180023394.0A CN202180023394A CN115335389A CN 115335389 A CN115335389 A CN 115335389A CN 202180023394 A CN202180023394 A CN 202180023394A CN 115335389 A CN115335389 A CN 115335389A
Authority
CN
China
Prior art keywords
compound
organ
alkyl
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180023394.0A
Other languages
English (en)
Chinese (zh)
Inventor
麦靖邦
H·弗莱里
马法书
M·皮尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ruinuo Medical Technology Shanghai Co ltd
Original Assignee
Ruinuo Medical Technology Shanghai Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ruinuo Medical Technology Shanghai Co ltd filed Critical Ruinuo Medical Technology Shanghai Co ltd
Publication of CN115335389A publication Critical patent/CN115335389A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analytical Chemistry (AREA)
CN202180023394.0A 2020-03-26 2021-03-25 亲环蛋白抑制剂及其用途 Pending CN115335389A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/081295 2020-03-26
CN2020081295 2020-03-26
CN2021078391 2021-03-01
CNPCT/CN2021/078391 2021-03-01
PCT/CN2021/083013 WO2021190601A1 (en) 2020-03-26 2021-03-25 Cyclophilin inhibitors and uses thereof

Publications (1)

Publication Number Publication Date
CN115335389A true CN115335389A (zh) 2022-11-11

Family

ID=77891510

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202180023394.0A Pending CN115335389A (zh) 2020-03-26 2021-03-25 亲环蛋白抑制剂及其用途
CN202180023172.9A Pending CN115298199A (zh) 2020-03-26 2021-03-25 环孢菌素衍生物的制备

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202180023172.9A Pending CN115298199A (zh) 2020-03-26 2021-03-25 环孢菌素衍生物的制备

Country Status (13)

Country Link
US (3) US12673976B2 (cg-RX-API-DMAC10.html)
EP (2) EP4126905B1 (cg-RX-API-DMAC10.html)
JP (2) JP7761578B2 (cg-RX-API-DMAC10.html)
KR (2) KR20220158760A (cg-RX-API-DMAC10.html)
CN (2) CN115335389A (cg-RX-API-DMAC10.html)
AU (1) AU2021240762A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022018929A2 (cg-RX-API-DMAC10.html)
CA (2) CA3172535A1 (cg-RX-API-DMAC10.html)
ES (1) ES3074820T3 (cg-RX-API-DMAC10.html)
IL (1) IL296586B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022011697A (cg-RX-API-DMAC10.html)
TW (1) TWI917366B (cg-RX-API-DMAC10.html)
WO (2) WO2021190601A1 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113329626A (zh) * 2019-01-20 2021-08-31 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries
GB202207348D0 (en) * 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof
TW202438040A (zh) * 2023-03-03 2024-10-01 大陸商睿諾醫療科技(上海)有限公司 劑誘導的肝臟病症或疾病的治療和預防
WO2024245384A1 (en) * 2023-06-02 2024-12-05 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964735A (zh) * 2004-04-08 2007-05-16 诺瓦提斯公司 环孢菌素用于治疗脑局部缺血以及脑和脊髓损伤的用途
WO2019016572A1 (en) * 2017-07-21 2019-01-24 Cypralis Ltd CICLOSPORINE ANALOGUES AND USES THEREOF
CN109476705A (zh) * 2016-05-17 2019-03-15 美国科技环球有限公司 新型环孢菌素衍生物及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
ATE254630T1 (de) 1998-06-12 2003-12-15 Chem Ag C Cyclosporine
US6809077B2 (en) 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
DK1436322T3 (da) 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
CA2518265A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
PT1802650E (pt) * 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
CN101068829B (zh) * 2004-10-01 2012-05-30 西尼克斯公司 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物
CA2652662C (en) * 2006-05-19 2015-11-03 Scynexis, Inc. Methods for the treatment and prevention of ocular disorders
WO2008143996A1 (en) * 2007-05-18 2008-11-27 Scynexis, Inc. New chemical processes
MX2011001152A (es) 2008-07-30 2011-06-09 Isotechnika Pharma Inc Moleculas de analogo de ciclosporina no-inmunesupresoras.
RU2492181C2 (ru) 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CA2785978A1 (en) * 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
DE102011111991A1 (de) 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
US20140213508A1 (en) 2012-10-19 2014-07-31 Scynexis, Inc. Antiviral macrocycles
GB201222455D0 (en) 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
GB201414806D0 (en) 2014-08-20 2014-10-01 Ucl Business Plc Cyclosporin conjugates
CN108025039B (zh) 2015-06-30 2022-07-29 西普拉里斯有限公司 新颖的大环化合物
CN106902347A (zh) * 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 亲环孢素抑制剂的用途
CN106902346A (zh) 2015-12-23 2017-06-30 中美华世通生物医药科技(武汉)有限公司 药物组合物及其制药用途
WO2020037530A1 (en) 2018-08-22 2020-02-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Crystalline form of compound and uses thereof in medicine
CN111449050A (zh) 2019-01-20 2020-07-28 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
CN116870135A (zh) 2019-10-12 2023-10-13 睿诺医疗科技(上海)有限公司 肾毒素诱发的肾损伤的治疗和预防
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
AU2021256222A1 (en) 2020-04-15 2022-10-06 Farsight Medical Technology (Shanghai) Co., Ltd. Prevention and treatment of organ injuries

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964735A (zh) * 2004-04-08 2007-05-16 诺瓦提斯公司 环孢菌素用于治疗脑局部缺血以及脑和脊髓损伤的用途
CN109476705A (zh) * 2016-05-17 2019-03-15 美国科技环球有限公司 新型环孢菌素衍生物及其用途
WO2019016572A1 (en) * 2017-07-21 2019-01-24 Cypralis Ltd CICLOSPORINE ANALOGUES AND USES THEREOF

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113329626A (zh) * 2019-01-20 2021-08-31 睿诺医疗科技(上海)有限公司 环孢菌素类似物及其用途
WO2026119135A1 (en) * 2024-12-03 2026-06-11 Farsight Medical Technology (Shanghai) Co., Ltd. Cyclophilin inhibitors and uses thereof

Also Published As

Publication number Publication date
US20240352074A1 (en) 2024-10-24
AU2021240762A1 (en) 2022-10-06
EP4126905C0 (en) 2026-05-13
TW202144379A (zh) 2021-12-01
KR20220158760A (ko) 2022-12-01
MX2022011697A (es) 2022-10-07
KR20220158761A (ko) 2022-12-01
CA3172601A1 (en) 2021-09-30
IL296586B1 (en) 2026-04-01
EP4126904A1 (en) 2023-02-08
US20230174583A1 (en) 2023-06-08
ES3074820T3 (es) 2026-07-23
US12522634B2 (en) 2026-01-13
CN115298199A (zh) 2022-11-04
JP7761578B2 (ja) 2025-10-28
EP4126905B1 (en) 2026-05-13
US12673976B2 (en) 2026-07-07
TWI917366B (zh) 2026-03-11
EP4126905A1 (en) 2023-02-08
WO2021190604A1 (en) 2021-09-30
US20230110497A1 (en) 2023-04-13
JP2023518776A (ja) 2023-05-08
EP4126905A4 (en) 2024-05-29
IL296586A (en) 2022-11-01
IL296586B2 (en) 2026-08-01
JP2023518777A (ja) 2023-05-08
CA3172535A1 (en) 2021-09-30
WO2021190601A1 (en) 2021-09-30
EP4126904A4 (en) 2024-05-29
JP7776435B2 (ja) 2025-11-26
BR112022018929A2 (pt) 2022-12-06
US12060440B2 (en) 2024-08-13

Similar Documents

Publication Publication Date Title
JP7776435B2 (ja) シクロフィリン阻害剤およびその使用
CN115315432A (zh) 亲环蛋白抑制剂及其用途
EP2318015B1 (en) Treatment of cancers of the blood using selected glycomimetic compounds
US20200171122A1 (en) Cyclosporin analogues and uses thereof
JP7839090B2 (ja) ネフロトキシン誘発性腎障害の処置及び予防
US20090156830A1 (en) Substituted Imidazoline Compounds
EP1711462A1 (de) Prolinderivate als pharmazeutische wirkstoffe in der tumortherapie
EA051978B1 (ru) Ингибиторы циклофилина и их применение
US12318368B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US7732485B2 (en) Treatment of cancer
KR20150014910A (ko) 허혈-재관류계 질환의 치료 화합물
KR101213600B1 (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물
US12435074B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12297175B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12384746B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
US12398128B2 (en) Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
KR20050039700A (ko) 이식거부 치료용 화합물 및 치료 방법
CN120936356A (zh) 以7-脱氢胆固醇或其盐、氧化物、代谢物或衍生物用于预防或治疗肺动脉高压的方法
KR0156985B1 (ko) 신규 2-클로로-3-치환아미노-1,4-나프탈렌디온 유도체
US20040152772A1 (en) 1-butyric acid derivatives and the use thereof
EP2601963A1 (en) N-isovaleroyl-l-glutamyl-l-tryptophan as an agent inhibiting the formation of ulcers in the stomach and the duodenum

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination